Page 4 - Heart Failure Guidelines

 

 

 

 

 

Page 4 - Heart Failure Guidelines
P. 4

Pediatric Heart Failure Guidelines

               Table of Contents

               Preface ...................................................................................................................................... 3
               Heart Failure - General Considerations ...................................................................................... 6
                  Heart Failure - Initial Evaluation .............................................................................................. 6
                  Heart Failure Disease Staging for Infants & Children .............................................................. 6
                  Heart Failure Symptom Severity Classification ....................................................................... 7
                  Heart Failure Medications ....................................................................................................... 8
                  Heart Failure Anticoagulation ................................................................................................11
                  Heart Failure Nutrition ...........................................................................................................11
                  Heart Failure Exercise ...........................................................................................................12
                  Heart Failure Advanced Therapies ........................................................................................13
                  Heart Failure Follow-up Schedule ..........................................................................................14
               Dilated Cardiomyopathy (DCM) ................................................................................................15

                  Additional Evaluation for DCM ...............................................................................................15
                  Medical Management DCM ...................................................................................................15
                  Follow-up Schedule for DCM .................................................................................................15
               Hypertrophic Cardiomyopathy (HCM) .......................................................................................16

                  Additional Diagnostic Evaluation for HCM .............................................................................16
                  Management HCM ................................................................................................................16
                  References ............................................................................................................................17
                  Obstruction Algorithm ............................................................................................................18
                  ICD Algorithm ........................................................................................................................19
                  Follow-up Schedule for Hypertrophic Cardiomyopathy ..........................................................20

               Restrictive Cardiomyopathy (RCM) ...........................................................................................20
                  Additional Evaluation for RCM ...............................................................................................20
                  Medical Management RCM ...................................................................................................20
                  Follow-up Schedule for Restrictive Cardiomyopathy ..............................................................21

               Non-Compaction Cardiomyopathy (LVNC) ................................................................................22
                  Additional Evaluation for LVCN .............................................................................................22
                  Medical Management for LVCN .............................................................................................22
                  Follow-up Schedule for LVCN ...............................................................................................22

               Congenital Heart Disease with Heart Failure .............................................................................23
                  Additional Evaluation for CHD with Heart Failure ...................................................................23
                  Management and Long-Term Follow-up for CHD with Heart Failure ......................................23
               Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) ......................................................24
                  Additional Evaluation for ARVC .............................................................................................24
                  Medical Management for ARVC ............................................................................................24
                  Follow up for ARVC ...............................................................................................................24
               Chemotherapy Induced Cardiomyopathy ..................................................................................25
                  Additional Evaluation for Patient with Chemotherapy Induced Cardiomyopathy ....................25



               Updated 7/31/2018                                                                       page 4
   1   2   3   4   5   6   7   8   9